AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Panico, S.
Right arrow Articles by Berrino, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Panico, S.
Right arrow Articles by Berrino, F.
Related Collections
Right arrow Cancer
Right arrow Cardiovascular Disease
Right arrow Prevention
Right arrow Mortality
Right arrow Women's Health

American Journal of Public Health, Vol 90, Issue 9 1397-1402, Copyright © 2000 by American Public Health Association

JOURNAL ARTICLE

Large-scale hormone replacement therapy and life expectancy: results from an international comparison among European and North American populations

S Panico, R Galasso, E Celentano, AV Ciardullo, L Frova, R Capocaccia, M Trevisan and F Berrino
Dipartimento di Medicina Clinica e Sperimentale, Federico II University, Naples, Italy. spanico@unina.it

OBJECTIVES: An analysis was performed to determine the risks and benefits of a 10-year hormone replacement therapy regimen that had been applied to all women at 50 years of age in 8 countries. METHODS: Cumulative mortality with and without hormone replacement therapy over 20 years was estimated, with both current and predicted total and disease-specific secular mortality trends and the influence of a generational cohort effect taken into account. RESULTS: In countries with high ischemic heart disease frequency and predictable relative predominance of ischemic heart disease rates over breast cancer rates for the next 20 years, hormone replacement therapy could result in benefits with regard to overall mortality; this advantage decreases in younger-generation cohorts. In countries in which breast cancer mortality predominates over ischemic heart disease in early postmenopause and in which the predictable trends for both diseases reinforce this condition, a negative effect on overall mortality would be observed. In the United States, the effect of large-scale hormone replacement therapy would change over time. CONCLUSIONS: The long-term effect of hormone replacement therapy on life expectancy of postmenopausal women may vary among countries.


This article has been cited by other articles:


Home page
 BMJHome page
S. Garattini and A. Liberati
The risk of bias from omitted research
BMJ, October 7, 2000; 321(7265): 845 - 846.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Public Health Association